Robert Herbst

Technik-/Wissenschafts-/F&E-Leiter bei IMMUNOGEN, INC.

Health Technology

Consumer Services

Aktive Positionen von Robert Herbst

Unternehmen	Position	Beginn	Ende
IMMUNOGEN, INC.	Technik-/Wissenschafts-/F&E-Leiter	-	-

University of Massachusetts

Doctorate Degree

International

Vereinigte Staaten

Operativ

Chief Tech/Sci/R&D Officer	1
Doctorate Degree	1

Sektoral

Health Technology	2
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	1
ImmunoGen, Inc. ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA.	Health Technology